South Rampart Pharma, Inc.
PrivateLast Round
Series A
Apr 10, 2025
Total Funding Raised
$2.3M
Company Overview
South Rampart Pharma, Inc. is a clinical-stage biopharmaceutical company that develops novel, non-opioid small molecule therapeutics designed to treat pain while avoiding the organ toxicity and addiction risks associated with current analgesics.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
South Rampart Pharma, Inc. Comps
Public and private peers based on sector, stage, and business model.
| Company | Status | Est. Valuation | Rev Multiple |
|---|---|---|---|
| OpenAI | Private | $86.0B | ~40x |
| Cohere | Private | $5.0B | -- |
| Competitor 1 | Public | $XX.XB | XXx |
| Competitor 2 | Public | $XX.XB | XXx |
South Rampart Pharma, Inc. Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A | Apr 10, 2025 | ||||
| Grant | Sep 21, 2023 | ||||
| Grant | Sep 29, 2020 |
South Rampart Pharma, Inc. Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Gulf South Angels | Series A |
| NIH RADx | Grant |
South Rampart Pharma, Inc. Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about South Rampart Pharma, Inc.'s valuation, stock price, and market status.